Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$223,788,674
-$361,151,249 QoQ
Shares Held
3,689,838
-66.0% QoQ
Ownership
0.181%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$5,394
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,860,542,672 across 13 Drug Manufacturers - General names. BMY ranks #6 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,377,822 | $581,234,808 | |
| 2 | LLY |
ELI LILLY & Co
|
576,174 | $529,947,557 | |
| 3 | PFE |
Pfizer Inc
|
16,082,788 | $451,604,686 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,778,301 | $334,201,827 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,310,515 | $322,016,474 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
3,689,838 | $223,788,674 | |
| 7 | NVO |
Novo Nordisk A S
|
3,046,611 | $111,962,952 | |
| 8 | AMGN |
Amgen Inc
|
316,917 | $111,507,246 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $223,788,674 | 3,689,838 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $5,394 | 100 | Put | Other | 2026-02-13 | |
| 2025-12-31 | $584,939,923 | 10,844,270 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $4,510 | 100 | Put | Other | 2025-11-13 | |
| 2025-09-30 | $69,164,818 | 1,533,588 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $220,571 | 4,765 | Shares | Other | 2025-08-13 | |
| 2024-09-30 | $44,915,959 | 868,109 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $10,620,466 | 255,730 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $47,406,998 | 874,184 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $19,695,990 | 339,352 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $6,145,595 | 96,100 | Call | Other | 2023-08-14 | |
| 2023-06-30 | $6,331,050 | 99,000 | Put | Other | 2023-08-14 | |
| 2023-06-30 | $123,713,128 | 1,934,529 | Shares | Other | 2023-08-14 | |
| 2022-12-31 | $4,584,725 | 63,721 | Shares | Other | 2023-02-14 | |
| 2022-03-31 | $4,207,988 | 57,620 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $37,410 | 600 | Call | Other | 2022-02-14 | |
| 2021-12-31 | $468,872 | 7,520 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $364,368 | 6,158 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $17,751 | 300 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $201,178 | 3,400 | Call | Sole | 2021-11-15 | |
| 2021-03-31 | $47,096,558 | 746,025 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $75,535,481 | 1,217,725 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $22,320,021 | 370,211 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $26,182,816 | 445,286 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $635,658 | 11,404 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||